Home / Oil and Gas / Prosthetic Heart Valves - Pipeline Review, 2015

Prosthetic Heart Valves - Pipeline Review, 2015

Published: Apr 2015 | No Of Pages: 309 | Published By: GlobalData

Prosthetic Heart Valves - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Prosthetic Heart Valves - Pipeline Review, 2015" provides an overview of Prosthetic Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key prosthetic heart valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Prosthetic Heart Valves products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Prosthetic Heart Valves and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Prosthetic Heart Valves under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 16
2 Introduction 17
2.1 Prosthetic Heart Valves Overview 17
3 Products under Development 18
3.1 Prosthetic Heart Valves - Pipeline Products by Stage of Development 18
3.2 Prosthetic Heart Valves - Pipeline Products by Segment 19
3.3 Prosthetic Heart Valves - Pipeline Products by Territory 20
3.4 Prosthetic Heart Valves - Pipeline Products by Regulatory Path 21
3.5 Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date 22
3.6 Prosthetic Heart Valves - Ongoing Clinical Trials 23
4 Prosthetic Heart Valves - Pipeline Products under Development by Companies 24
4.1 Prosthetic Heart Valves Companies - Pipeline Products by Stage of Development 24
4.2 Prosthetic Heart Valves - Pipeline Products by Stage of Development 27
5 Prosthetic Heart Valves Companies and Product Overview 31
5.1 Aegis Surgical Limited Company Overview 31
5.1.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 AorTech International plc Company Overview 32
5.2.1 AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview 32
5.3 Apica Cardiovascular Limited Company Overview 34
5.3.1 Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Boston Children's Hospital Company Overview 35
5.4.1 Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 35
5.5 Boston Scientific Corporation Company Overview 37
5.5.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Braile Biomedica Ltda. Company Overview 46
5.6.1 Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 Caisson Interventional, LLC Company Overview 48
5.7.1 Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Cardiac Dimensions, Inc. Company Overview 49
5.8.1 Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.9 CardiAQ Valve Technologies, Inc. Company Overview 53
5.9.1 CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.10 Cardio3 BioSciences SA Company Overview 59
5.10.1 Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview 59
5.11 Cephea Valve Technologies, Inc. Company Overview 60
5.11.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 Clemson University Company Overview 61
5.12.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Colibri Heart Valve, LLC Company Overview 62
5.13.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 CorMatrix Cardiovascular, Inc. Company Overview 70
5.14.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.15 CryoLife, Inc. Company Overview 75
5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.16 Cytograft Tissue Engineering, Inc. Company Overview 77
5.16.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.17 Direct Flow Medical, Inc. Company Overview 78
5.17.1 Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.18 Dura Biotech Company Overview 83
5.18.1 Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
5.19 Edwards Lifesciences Corporation Company Overview 85
5.19.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.20 Emory University Company Overview 106
5.20.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 106
5.21 HighLife SAS Company Overview 108
5.21.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 108
5.22 HLT, Inc. Company Overview 109
5.22.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.23 Innovia LLC Company Overview 112
5.23.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 112
5.24 JenaValve Technology GmbH Company Overview 115
5.24.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 115
5.25 Leman Cardiovascular Company Overview 120
5.25.1 Leman Cardiovascular Pipeline Products & Ongoing Clinical Trials Overview 120
5.26 Mayo Clinic Company Overview 121
5.26.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 121
5.27 Medi-Line S.A. Company Overview 122
5.27.1 Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview 122
5.28 Medtronic plc Company Overview 123
5.28.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 123
5.29 Meril Life Sciences Pvt. Ltd. Company Overview 135
5.29.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 135
5.30 Micro Interventional Devices, Inc. Company Overview 136
5.30.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.31 MicroPort Scientific Corporation Company Overview 138
5.31.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 138
5.32 Mitralix Ltd. Company Overview 142
5.32.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.33 MitrAssist Ltd. Company Overview 143
5.33.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 143
5.34 Mitricares Company Overview 144
5.34.1 Mitricares Pipeline Products & Ongoing Clinical Trials Overview 144
5.35 NaviGate Cardiac Structures, Inc. Company Overview 145
5.35.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145
5.36 Neovasc Inc. Company Overview 146
5.36.1 Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview 146
5.37 Peca Labs, Inc. Company Overview 150
5.37.1 Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.38 PolyNova Cardiovascular LLC Company Overview 151
5.38.1 PolyNova Cardiovascular LLC Pipeline Products & Ongoing Clinical Trials Overview 151
5.39 RegenaGraft Company Overview 152
5.39.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 152
5.40 Revivicor, Inc. Company Overview 153
5.40.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.41 SAS Cormove Company Overview 154
5.41.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview 154
5.42 Scientific and Production Center Amphion, LLC Company Overview 155
5.42.1 Scientific and Production Center Amphion, LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.43 Sorin S.p.A. Company Overview 156
5.43.1 Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 156
5.44 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 160
5.44.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 160
5.45 St. Jude Medical, Inc. Company Overview 162
5.45.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
5.46 Stellenbosch University Company Overview 175
5.46.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 175
5.47 Strait Access Technologies (Pty) Ltd Company Overview 176
5.47.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 176
5.48 Symetis AG Company Overview 178
5.48.1 Symetis AG Pipeline Products & Ongoing Clinical Trials Overview 178
5.49 Tendyne Medical, Inc. Company Overview 184
5.49.1 Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.50 The Tel Aviv Sourasky Medical Center Company Overview 187
5.50.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 187
5.51 Thubrikar Aortic Valve, Inc. Company Overview 188
5.51.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 188
5.52 Tissue Regenix Ltd Company Overview 190
5.52.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 190
5.53 Transcatheter Technologies GmbH Company Overview 193
5.53.1 Transcatheter Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 193
5.54 Twelve, Inc Company Overview 196
5.54.1 Twelve, Inc Pipeline Products & Ongoing Clinical Trials Overview 196
5.55 UMC Utrecht Holding BV Company Overview 197
5.55.1 UMC Utrecht Holding BV Pipeline Products & Ongoing Clinical Trials Overview 197
5.56 University College London Company Overview 198
5.56.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 198
5.57 University of California, Irvine Company Overview 199
5.57.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 199
5.58 University of Pennsylvania Company Overview 202
5.58.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 202
5.59 Valtech Cardio Ltd. Company Overview 204
5.59.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 204
5.60 ValveXchange, Inc. Company Overview 205
5.60.1 ValveXchange, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.61 VueKlar Cardiovascular Ltd. Company Overview 208
5.61.1 VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 208
5.62 Xeltis AG Company Overview 210
5.62.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 210
6 Prosthetic Heart Valves- Recent Developments 211
7 Appendix 306
7.1 Methodology 306
7.2 About GlobalData 308
7.3 Contact Us 309
7.4 Disclaimer 309

1.1 List of Tables
Table 1: Prosthetic Heart Valves - Pipeline Products by Stage of Development 18
Table 2: Prosthetic Heart Valves - Pipeline Products by Segment 19
Table 3: Prosthetic Heart Valves - Pipeline Products by Territory 20
Table 4: Prosthetic Heart Valves - Pipeline Products by Regulatory Path 21
Table 5: Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date 22
Table 6: Prosthetic Heart Valves - Ongoing Clinical Trials 23
Table 7: Prosthetic Heart Valves Companies - Pipeline Products by Stage of Development 24
Table 8: Prosthetic Heart Valves - Pipeline Products by Stage of Development 27
Table 9: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 31
Table 10: pTAo-TAVR - Product Status 31
Table 11: pTAo-TAVR - Product Description 31
Table 12: AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 13: AorTech Polymer Valve - Product Status 32
Table 14: AorTech Polymer Valve - Product Description 33
Table 15: Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 34
Table 16: Next Generation Device For TAVI - Product Status 34
Table 17: Next Generation Device For TAVI - Product Description 34
Table 18: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 35
Table 19: Two Piece Replacement Heart Valve Apparatus - Product Status 35
Table 20: Two Piece Replacement Heart Valve Apparatus - Product Description 36
Table 21: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
Table 22: 21 mm Lotus Valve System - Product Status 37
Table 23: 21 mm Lotus Valve System - Product Description 38
Table 24: 23 mm Lotus Valve System - Product Status 38
Table 25: 23 mm Lotus Valve System - Product Description 38
Table 26: 25 mm Lotus Valve System - Product Status 39
Table 27: 25 mm Lotus Valve System - Product Description 39
Table 28: 27 mm Lotus Valve System - Product Status 40
Table 29: 27 mm Lotus Valve System - Product Description 40
Table 30: 29 mm Lotus Valve System - Product Status 41
Table 31: 29 mm Lotus Valve System - Product Description 41
Table 32: Boston Scientific Corporation - Ongoing Clinical Trials Overview 42
Table 33: 23 mm Lotus Valve System - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System (REPRISE I) 43
Table 34: 23 mm Lotus Valve System - REPRISE II: Repositionable Percutaneous Replacement Of Stenotic Aortic Valve Through Implantation Of Lotus Valve System: Evaluation Of Safety And Performance 43
Table 35: 23 mm Lotus Valve System - RESPOND: Repositionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes 43
Table 36: 27 mm Lotus Valve System - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve With the Next Generation Delivery System: REPRISE NGDS 44
Table 37: 25 mm Lotus Valve System - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation (REPRISE III) 45
Table 38: Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 39: Inovare Valve - Product Status 46
Table 40: Inovare Valve - Product Description 47
Table 41: Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
Table 42: Caisson TMVR - Product Status 48
Table 43: Caisson TMVR - Product Description 48
Table 44: Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 45: CARILLON Mitral Contour System - Product Status 49
Table 46: CARILLON Mitral Contour System - Product Description 49
Table 47: Enhanced CARILLON Mitral Contour System - Product Status 50
Table 48: Enhanced CARILLON Mitral Contour System - Product Description 50
Table 49: Cardiac Dimensions, Inc. - Ongoing Clinical Trials Overview 51
Table 50: CARILLON Mitral Contour System - COMPETENT Pilot Study of the CARILLON Mitral Contour System for Treatment of Functional Mitral Regurgitation 52
Table 51: CARILLON Mitral Contour System - Evaluation of Safety and Efficacy of The CARILLON Device 52
Table 52: CARILLON Mitral Contour System - Safety and Efficacy of the CARILLON Mitral Contour System in Reducing Functional Mitral Regurgitation (FMR) Associated with Heart Failure: The REDUCE FMR Trial 52
Table 53: CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 54: Second Generation Transapical Transcatheter Mitral Valve - Product Status 53
Table 55: Second Generation Transapical Transcatheter Mitral Valve - Product Description 53
Table 56: Second Generation Transfemoral Transcatheter Mitral Valve - Product Status 54
Table 57: Second Generation Transfemoral Transcatheter Mitral Valve - Product Description 54
Table 58: Transcatheter Mitral Valve Implantation System - Product Status 55
Table 59: Transcatheter Mitral Valve Implantation System - Product Description 55
Table 60: CardiAQ Valve Technologies, Inc. - Ongoing Clinical Trials Overview 56
Table 61: Second Generation Transapical Transcatheter Mitral Valve - Early Feasibility Study Using the CardiAQ Second-generation Transfemoral (TF) and Transapical (TA) Transcatheter Mitral Valve Implantation (TMVI) Systems 57
Table 62: Second Generation Transfemoral Transcatheter Mitral Valve - Early Feasibility Study Using the CardiAQ Second-generation Transfemoral (TF) and Transapical (TA) Transcatheter Mitral Valve Implantation (TMVI) Systems 58
Table 63: Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview 59
Table 64: Mitral Valve Neo-chordae - Product Status 59
Table 65: Mitral Valve Neo-chordae - Product Description 59
Table 66: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 67: Mitral Valve Replacement Device - Product Status 60
Table 68: Mitral Valve Replacement Device - Product Description 60
Table 69: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 61
Table 70: Mechanical Heart Valve - Product Status 61
Table 71: Mechanical Heart Valve - Product Description 61
Table 72: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
Table 73: Colibri Aortic Heart Valve - 24mm - Product Status 62
Table 74: Colibri Aortic Heart Valve - 24mm - Product Description 62
Table 75: Colibri Aortic Heart Valve - 21mm - Product Status 63
Table 76: Colibri Aortic Heart Valve - 21mm - Product Description 63
Table 77: Colibri Aortic Heart Valve - 27mm - Product Status 63
Table 78: Colibri Aortic Heart Valve - 27mm - Product Description 64
Table 79: Colibri TAVI Device - Product Status 64
Table 80: Colibri TAVI Device - Product Description 64
Table 81: Custom Delivery System - Product Status 65
Table 82: Custom Delivery System - Product Description 65
Table 83: Delta Aortic Heart Valve - Product Status 65
Table 84: Delta Aortic Heart Valve - Product Description 66
Table 85: Pulmonary Valve - Product Status 66
Table 86: Pulmonary Valve - Product Description 66
Table 87: Sutureless Surgical Aortic Valve - Product Status 67
Table 88: Sutureless Surgical Aortic Valve - Product Description 67
Table 89: Colibri Heart Valve, LLC - Ongoing Clinical Trials Overview 68
Table 90: Colibri TAVI Device - Colibri TAVI System, First Ready-to-Use Transcatheter Heart Valve System: A Prospective, Multicenter, Non-Randomized, Investigational Study 69
Table 91: CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 92: CorMatrix ECM - Heart Valve Repair - Product Status 70
Table 93: CorMatrix ECM - Heart Valve Repair - Product Description 70
Table 94: CorMatrix ECM - Heart Valve Replacement - Product Status 71
Table 95: CorMatrix ECM - Heart Valve Replacement - Product Description 71
Table 96: CorMatrix ECM Tricuspid Heart Valve - Product Status 71
Table 97: CorMatrix ECM Tricuspid Heart Valve - Product Description 72
Table 98: Pediatric Prosthetic Trileaflet Valve - Product Status 72
Table 99: Pediatric Prosthetic Trileaflet Valve - Product Description 72
Table 100: CorMatrix Cardiovascular, Inc. - Ongoing Clinical Trials Overview 73
Table 101: CorMatrix ECM Tricuspid Heart Valve - Early Feasibility and Investigational Device Exemption Study of CorMatrix ECM Tricuspid Heart Valve 74
Table 102: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 103: CryoValve SGAV - Product Status 75
Table 104: CryoValve SGAV - Product Description 76
Table 105: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
Table 106: Cytograft Valve - Product Status 77
Table 107: Cytograft Valve - Product Description 77
Table 108: Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 109: 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Status 78
Table 110: 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Description 79
Table 111: 23mm Direct Flow Medical Transcatheter Aortic Valve System - Product Status 79
Table 112: 23mm Direct Flow Medical Transcatheter Aortic Valve System - Product Description 79
Table 113: Direct Flow Medical, Inc. - Ongoing Clinical Trials Overview 80
Table 114: 18F Direct Flow Medical Transcatheter Aortic Valve System - A Registry To Evaluate The Direct Flow Medical Transcatheter Aortic Valve System For The Treatment Of Patients With Severe Aortic Stenosis 81
Table 115: 18F Direct Flow Medical Transcatheter Aortic Valve System - Direct Flow Medical Transcatheter Aortic Valve System Demonstrates Trial Outcomes in SALUS Trial 81
Table 116: 18F Direct Flow Medical Transcatheter Aortic Valve System - The Direct Flow Medical Transcatheter Aortic Valve Replacement System a US Pivotal Trial 81
Table 117: 18F Direct Flow Medical Transcatheter Aortic Valve System - The Direct Flow Medical TranScatheter Aortic Valve RepLacement System US Feasibility Trial 82
Table 118: Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
Table 119: Dura Heart Valve - Product Status 83
Table 120: Dura Heart Valve - Product Description 83
Table 121: LowPro Valve - Product Status 84
Table 122: LowPro Valve - Product Description 84
Table 123: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
Table 124: Edwards CENTERA Valve - Product Status 86
Table 125: Edwards CENTERA Valve - Product Description 86
Table 126: Edwards SAPIEN 3 Valve - Product Status 86
Table 127: Edwards SAPIEN 3 Valve - Product Description 87
Table 128: Edwards SAPIEN Pulmonic Transcatheter Heart Valve - Product Status 87
Table 129: Edwards SAPIEN Pulmonic Transcatheter Heart Valve - Product Description 87
Table 130: Edwards SAPIEN XT Valve - 20mm - Product Status 88
Table 131: Edwards SAPIEN XT Valve - 20mm - Product Description 88
Table 132: FORTIS Mitral Transcatheter Heart Valve - Product Status 88
Table 133: FORTIS Mitral Transcatheter Heart Valve - Product Description 89
Table 134: GLX Aortic Conduit - Product Status 89
Table 135: GLX Aortic Conduit - Product Description 89
Table 136: INTUITY ELITE - Product Status 90
Table 137: INTUITY ELITE - Product Description 90
Table 138: INTUITY Valve System - Product Status 90
Table 139: INTUITY Valve System - Product Description 91
Table 140: Magna EASE Surgical Valve With GLX - Product Status 91
Table 141: Magna EASE Surgical Valve With GLX - Product Description 91
Table 142: Next Gen CENTERA - Product Status 92
Table 143: Next Gen CENTERA - Product Description 92
Table 144: Next Gen SAPIEN - Product Status 92
Table 145: Next Gen SAPIEN - Product Description 93
Table 146: SAPIEN XT – Valve-In-Valve Indication - Product Status 93
Table 147: SAPIEN XT – Valve-In-Valve Indication - Product Description 93
Table 148: ZETA Platform - Product Status 94
Table 149: ZETA Platform - Product Description 94
Table 150: Edwards Lifesciences Corporation - Ongoing Clinical Trials Overview 95
Table 151: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement 97
Table 152: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve 97

1.2 List of Figures
Figure 1: Prosthetic Heart Valves - Pipeline Products by Stage of Development 18
Figure 2: Prosthetic Heart Valves - Pipeline Products by Segment 19
Figure 3: Prosthetic Heart Valves - Pipeline Products by Territory 20
Figure 4: Prosthetic Heart Valves - Pipeline Products by Regulatory Path 21
Figure 5: Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date 22
Figure 6: Prosthetic Heart Valves - Ongoing Clinical Trials 23

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +